文献速递临床试验与 GCP医学人工智能与信息学真实世界研究与卫生经济

基于临床决策支持系统与物联网的综合高血压管理系统在基层医疗中的效果:CATCH试验研究方案

Effectiveness of a CDSS and Internet of Things-based comprehensive hypertension management system in primary health care settings: study protocol for the CATCH Trial.
PubMed 文献 · Trials · 2026-01-27

本研究为在深圳市龙岗区第三人民医院12家社区健康服务中心开展的阶梯楔形整群随机对照试验,评估由高血压辅助决策模块、临床诊疗知识教育系统和质量控制系统组成的CATCH系统对基层高血压管理的作用。所有中心均接受干预,每阶段3个月,整个试验在12个月内完成。

要点

  • CATCH系统整合临床决策支持系统与物联网,为基层医生提供高血压诊疗决策支持。
  • 研究采用阶梯楔形整群随机设计,12个中心分4组、5个阶段,每阶段3个月。
  • 纳入标准为社区登记且筛查时收缩压≥140 mmHg和/或舒张压≥90 mmHg的参与者。

核心结论

  • CATCH试验利用临床决策支持系统与物联网改善基层高血压管理,通过远程监测和质量控制提高指南依从性和患者结局。
  • 所有中心均接受干预以确保公平可及,结果将指导未来高血压策略。

研究设计与样本

  • 研究为在深圳市龙岗区第三人民医院12家社区健康服务中心开展的阶梯楔形整群随机对照试验。
  • 12个整群按随机方法分为4组、5个阶段,每阶段持续3个月,确保整个试验在12个月内完成。
  • 纳入社区登记且筛查时收缩压≥140 mmHg和/或舒张压≥90 mmHg的参与者。

关键数值与推荐

  • 干预为CATCH系统,由高血压辅助决策模块、临床诊疗知识教育系统和质量控制系统组成。
  • 纳入标准为筛查时收缩压≥140 mmHg和/或舒张压≥90 mmHg。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular and cerebrovascular diseases are the leading causes of death in the Chinese population, and hypertension is one of the key risk factors. However, the blood pressure control rate of hypertensive patients is low at present. The main factors include the limited capacity of primary care workers and poor self-management among hypertensives. The purpose of this program is to use a clinical decision support system (CDSS) and an Internet of Things-based comprehensive hypertension management system (CATCH) to provide decision support for the diagnosis and treatment of hypertension for primary care clinicians and to improve the standardisation of the diagnosis, monitoring, treatment, and continuous management of hypertension among them. METHODS: This study is a stepped wedge cluster randomised controlled trial conducted in 12 community health centres in the Third People's Hospital of Longgang District, Shenzhen City, China. All participants who are registered in the community and with systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg at the screening clinic will be asked to participate in the study. The intervention is a CATCH composite of a hypertension auxiliary decision-making module, clinical diagnosis and treatment knowledge education system, and quality control system. All 12 clusters will be divided into 4 clusters and 5 stages according to a randomised method, with each stage lasting 3 months, ensuring that the entire trial will be completed within 12 months. DISCUSSION: The CATCH trial uses CDSS and IoT to improve hypertension management in primary care. This stepped wedge trial enhances guideline adherence and patient outcomes through remote monitoring and quality control. All centres receive the intervention, ensuring equitable access to it. Results will guide future hypertension strategies. TRIAL REGISTRATION: The trial was registered at the National Medical Research Registration and Record Filing Information System of China in December 2024, was retrospectively registered at the Chinese Clinical Trial Registry (ChiCTR) (Registration number: ChiCTR2500098845) https://www.chictr.org.cn/.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li B, Peng K, Xu K, et al. Effectiveness of a CDSS and Internet of Things-based comprehensive hypertension management system in primary health care settings: study protocol for the CATCH Trial. Trials. 2026. PMID: 41588416. doi:10.1186/s13063-025-09349-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。